ABR-001

N/A

Report date: 2025/08/13 16:51:10

Base Information

Drug NameABR-001
Drug Alias NameABR-001
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR > CRISPR-Cas12 > CRISPR-Cas12i2
Mechanisms of ActionHydroxyacid oxidase 1 modulators
TargetsHydroxyacid oxidase 1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArbor Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesArbor Biotechnologies Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A